Evidence map›Paper›PMID 38773317›Full record

ArticleScientific reports2024

Dissecting causal relationships between primary biliary cholangitis and extrahepatic autoimmune diseases based on Mendelian randomization.

Gang Ma, Jiaqi Yang, Xingguo Wang, Erzhuo Xia, Jiahao Yu, Miao Zhang, Yinan Hu, Shuoyi Ma, Xia Zhou, Qingling Fan and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gang Ma *Xijing Hospital of Digestive Disease, Xijing Hospital of Air Force Military Medical University, Xi'an, China.
Jiaqi Yang *Xijing Hospital of Digestive Disease, Xijing Hospital of Air Force Military Medical University, Xi'an, China.
Xingguo Wang *Xijing Hospital of Obstetrics and Gynecology, Xijing Hospital of Air Force Military Medical University, Xi'an, China.
Erzhuo XiaXijing Hospital of Digestive Disease, Xijing Hospital of Air Force Military Medical University, Xi'an, China.
Jiahao YuXijing Hospital of Digestive Disease, Xijing Hospital of Air Force Military Medical University, Xi'an, China.
Miao ZhangXijing Hospital of Digestive Disease, Xijing Hospital of Air Force Military Medical University, Xi'an, China.
Yinan HuXijing Hospital of Digestive Disease, Xijing Hospital of Air Force Military Medical University, Xi'an, China.
Shuoyi MaXijing Hospital of Digestive Disease, Xijing Hospital of Air Force Military Medical University, Xi'an, China.
Xia ZhouXijing Hospital of Digestive Disease, Xijing Hospital of Air Force Military Medical University, Xi'an, China.
Qingling FanXijing Hospital of Digestive Disease, Xijing Hospital of Air Force Military Medical University, Xi'an, China.
Ying HanXijing Hospital of Digestive Disease, Xijing Hospital of Air Force Military Medical University, Xi'an, China. hanying1@fmmu.edu.cn.
Jingbo WangXijing Hospital of Digestive Disease, Xijing Hospital of Air Force Military Medical University, Xi'an, China. jimberw@163.com.

Funding

National Key Research and Development (R&D) Program of China No. 2020YFA0710803National Natural Science Foundation of China No. 81820108005
6 · The paper itself

Abstract

As an autoimmune disease, up to 73% of patients with primary biliary cholangitis (PBC) have a combination of extrahepatic autoimmune diseases (EHAIDs); however, the causal relationship between PBC and EHAIDs is unclear. The genome-wide association analyses provided 14 GWAS data for PBC and EHAIDs, and bidirectional, two-sample MR analyses were performed to examine the relationship between PBC and EHAIDs. The analysis using MR provides a strong and meaningful estimation of the bidirectional correlation between PBC and 7 EHAIDs: rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, systemic sclerosis, autoimmune hypothyroidism, inflammatory bowel disease and ulcerative colitis of its types. In addition, PBC increases the risk of autoimmune thyroid diseases such as autoimmune hyperthyroidism and Graves' disease, as well as multiple sclerosis and psoriasis. Additionally, PBC is identified as a risk factor for Crohn's disease and Celiac disease. Based on genetic evidence, there may be connections between PBC and specific EHAIDs: not all coexisting EHAIDs induce PBC, and vice versa. This underscores the significance of prioritizing PBC in clinical practice. Additionally, if any liver function abnormalities are observed during treatment or with EHAIDs, it is crucial to consider the possibility of comorbid PBC.

Indexed as

Autoimmune DiseasesGenome-Wide Association StudyLiver Cirrhosis, BiliaryMendelian Randomization AnalysisArthritis, RheumatoidCeliac DiseaseColitis, UlcerativeCrohn DiseaseGenetic Predisposition to DiseaseGraves DiseaseHumansInflammatory Bowel DiseasesLupus Erythematosus, SystemicMultiple SclerosisPolymorphism, Single NucleotidePsoriasisCausal effectExtrahepatic autoimmune diseasesGenetic epidemiologyMendelian randomizationPrimary biliary cholangitis

Identifiers

PMID38773317
PMCPMC11109240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.